This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Jul;21(7):1391-1393.

doi: 10.1093/annonc/mdq266. Epub 2010 May 25.

Looking for efficiency rather than efficacy in randomized controlled trials in oncology

I Floriani¹, S Garattini², V Torri²

Affiliations

Affiliations

¹ Laboratory of Clinical Trials, Department of Oncology, Mario Negri Institution, Milan, Italy. Electronic address: irene.floriani@marionegri.it.
² Laboratory of Clinical Trials, Department of Oncology, Mario Negri Institution, Milan, Italy.

PMID: 20501504
DOI: 10.1093/annonc/mdq266

Free article

Editorial

Looking for efficiency rather than efficacy in randomized controlled trials in oncology

I Floriani et al. Ann Oncol. 2010 Jul.

Free article

. 2010 Jul;21(7):1391-1393.

doi: 10.1093/annonc/mdq266. Epub 2010 May 25.

Authors

I Floriani¹, S Garattini², V Torri²

Affiliations

¹ Laboratory of Clinical Trials, Department of Oncology, Mario Negri Institution, Milan, Italy. Electronic address: irene.floriani@marionegri.it.
² Laboratory of Clinical Trials, Department of Oncology, Mario Negri Institution, Milan, Italy.

PMID: 20501504
DOI: 10.1093/annonc/mdq266

No abstract available

PubMed Disclaimer

Similar articles

Stopping a trial early in oncology: for patients or for industry?
Whitehead J, Cobo E. Whitehead J, et al. Ann Oncol. 2008 Aug;19(8):1512-1513. doi: 10.1093/annonc/mdn410. Epub 2008 Jul 10. Ann Oncol. 2008. PMID: 18621741 No abstract available.
New designs for basket clinical trials in oncology.
Simon R. Simon R. J Biopharm Stat. 2018;28(2):245-255. doi: 10.1080/10543406.2017.1372779. Epub 2017 Oct 30. J Biopharm Stat. 2018. PMID: 28877003 Review.
Randomized trials in oncology: a fertile ground for controversy.
Markman M. Markman M. Curr Oncol Rep. 2003 Sep;5(5):347-8. doi: 10.1007/s11912-003-0014-x. Curr Oncol Rep. 2003. PMID: 12895382 No abstract available.
Stopping a trial early in oncology: for patients or for industry?
Bradbury P, Meyer R, Pater J, Tu D, Seymour L, Shepherd L, Eisenhauer E. Bradbury P, et al. Ann Oncol. 2009 Feb;20(2):395-6. doi: 10.1093/annonc/mdn753. Epub 2009 Jan 15. Ann Oncol. 2009. PMID: 19150952 No abstract available.
Comparative effectiveness research: opportunities in surgical oncology.
Neuman HB, Greenberg CC. Neuman HB, et al. Semin Radiat Oncol. 2014 Jan;24(1):43-8. doi: 10.1016/j.semradonc.2013.09.003. Semin Radiat Oncol. 2014. PMID: 24314341 Review.

See all similar articles

Cited by

Hurdles in anticancer drug development from a regulatory perspective.
Jonsson B, Bergh J. Jonsson B, et al. Nat Rev Clin Oncol. 2012 Feb 21;9(4):236-43. doi: 10.1038/nrclinonc.2012.14. Nat Rev Clin Oncol. 2012. PMID: 22349015 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.